Remove Branding Remove Marketing Remove Protein
article thumbnail

Current and future players in the lupus market

Pharmaceutical Technology

As such, the SLE and LN marketplace is dominated by generics, and GSK’s Benlysta and AstraZeneca’s Saphnelo are the only drugs that have gained marketing approval specifically for SLE in more than 50 years. In previous years, Benlysta has managed to grow the lupus market in terms of value, having generated approximately $492.9m

Marketing 278
article thumbnail

Faba Bean Protein: Overcoming Formulation Challenges in Protein-Enriched Food Applications

XTalks

In today’s food and beverage industry, protein enrichment has become a pivotal trend, driven by consumers’ growing awareness of health and nutrition. High-protein products are in demand across various categories, from bakery and dairy (alternatives) to sports nutrition and savoury foods.

Protein 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nestlé Tops List of Most Valuable Food Brands in 2023

XTalks

Food giant Nestlé has once again claimed the top spot on the list of the world’s most valuable food brands in Brand Finance’s “Food & Drink 2023” report. To generate the report, Brand Finance conducted original market research on over 5,000 brands, covering 38 countries and 31 sectors.

Branding 105
article thumbnail

Protein Bread Brand EQUII Expands Its High-Protein, Low-Carb Offerings

XTalks

EQUII, a food tech startup renowned for its protein bread that focuses on high complete protein and low carbs, is expanding its product line. This new range, which debuted at Expo East last week, includes Plain and Multigrain protein bread, delivering consumers a blend of nutrition without compromising on flavor.

Protein 59
article thumbnail

COVID-19 Vaccine Brand Names: Moderna Secures Spikevax in Europe While Pfizer is Comirnaty

XTalks

Moderna has won approval from the European Medicines Association (EMA) for branding its COVID-19 vaccine with the name Spikevax. With the approval, Moderna’s Spikevax joins Pfizer-BioNTech’s Comirnaty and AstraZeneca’s Vaxzevria with European brand-name approvals. It partnered on over 75 percent of approved drug names in 2020.

article thumbnail

Why Maple Leaf Foods is Reevaluating its Plant Protein Business

XTalks

Maple Leaf Foods, one of Canada’s largest pork and poultry processors, announced yesterday it would be reevaluating its plant-based protein business. The company’s third-quarter financial results revealed that while its meat group performed well, there was a slowdown in its plant-based protein segment. Sales in the category fell 6.6

Protein 95
article thumbnail

Why Pet Food Acquisitions Are On the Rise Among Meat and Poultry Brands

XTalks

The COVID-19 pandemic influenced 47 percent of new dog adoptions, so it’s only logical that big food brands would start making acquisitions of their own. Specifically, meat and poultry brands, along with some “human food” brands, are acquiring pet food businesses. The first is natural integration into existing supply chains.